Jan 19, 2023 09:37AM
Nov 17, 2022 08:00AM
Nov 17, 2022 08:00AM
Nov 16, 2022 08:00AM
Nov 16, 2022 08:00AM
Nov 4, 2022 08:00AM
Nov 4, 2022 08:00AM Ayala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Oct 19, 2022 06:31AM
Oct 19, 2022 06:30AM
Oct 19, 2022 06:30AM
Oct 19, 2022 06:30AM
Sep 29, 2022 08:00AM
Sep 29, 2022 08:00AM
Sep 27, 2022 08:01AM Ayala Pharmaceuticals Inc. (AYLA) Granted FDA Fast Track Designation for AL102
Sep 27, 2022 08:00AM
Sep 27, 2022 08:00AM
Sep 12, 2022 08:02AM
Sep 12, 2022 08:00AM
Sep 12, 2022 08:00AM
Aug 24, 2022 08:00AM
Aug 24, 2022 08:00AM Ayala Pharmaceuticals Selected to Present Efficacy and Tolerability Data on AL102 in Desmoid Tumors at the European Society for Medical Oncology (ESMO) 2022 Congress
Aug 15, 2022 04:05PM
Aug 15, 2022 04:05PM
Jul 5, 2022 08:01AM
Jul 5, 2022 08:00AM
Jul 5, 2022 08:00AM
Jun 6, 2022 08:00AM
Jun 6, 2022 08:00AM Ayala Pharmaceuticals Announces Data on AL101 in Adenoid Cystic Carcinoma (ACC) at 2022 ASCO Annual Meeting
Jun 2, 2022 08:00AM
Jun 2, 2022 08:00AM
May 16, 2022 04:05PM
May 16, 2022 04:05PM
Apr 27, 2022 10:30AM
Apr 27, 2022 10:30AM
Mar 28, 2022 04:05PM Ayala Pharmaceuticals Reports Full-Year 2021 Financial Results and Provides Corporate Update
Mar 28, 2022 04:05PM
Mar 9, 2022 08:00AM
Mar 9, 2022 08:00AM
Mar 8, 2022 08:00AM
Mar 8, 2022 08:00AM
Feb 23, 2022 08:00AM
Feb 23, 2022 08:00AM Ayala Pharmaceuticals Announces Completion of Enrollment in Part A of RINGSIDE, a Pivotal Phase 2/3 Study of AL102 in Desmoid Tumors
Jan 6, 2022 08:28AM
Jan 6, 2022 08:28AM
Jan 4, 2022 08:10AM
Jan 4, 2022 08:00AM
Jan 4, 2022 08:00AM
Dec 20, 2021 08:18AM
Nov 15, 2021 08:00AM Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 10, 2021 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All